Phase II study of neo-adjuvant chemotherapy for locally advanced gastric cancer

BACKGROUND: Neoadjuvant chemotherapy improves survival of locally advanced gastric cancer patients. However, benefit is limited and the best regimen remains controversial. OBJECTIVES: Our primary objective of this prospective, multicenter phase 2 study was to evaluate the pathological complete respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Alex Yuang-Chi, Foo, Kian Fong, Koo, Wen-Hsin, Ong, Simon, So, Jimmy, Tan, Daniel, Lim, Khong Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Gastric Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013330/
https://www.ncbi.nlm.nih.gov/pubmed/27648294
http://dx.doi.org/10.1136/bmjgast-2016-000095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013330/
https://www.ncbi.nlm.nih.gov/pubmed/27648294
http://dx.doi.org/10.1136/bmjgast-2016-000095

Ejemplares similares